Granules India Limited has informed the Exchange regarding a press release dated April 10, 2025, titled "Granules India Announces Closing of Acquisition of Senn Chemicals, Strengthening Capabilities in Peptide Therapeutics and CDMO Services".
GRANULES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Granules India Limited has completed the acquisition of Senn Chemicals, as announced in a press release dated April 10, 2025. This move is aimed at strengthening the company's capabilities in peptide therapeutics and CDMO (Contract Development and Manufacturing Organization) services. The acquisition marks a strategic step into the high-growth peptide therapeutics space. No financial details such as deal value or payment terms were disclosed in the filing.
This acquisition could expand Granules India's revenue streams by adding peptide-based APIs and CDMO services, which are in growing global demand. Shareholders may view this positively as it diversifies the business beyond generics into higher-value specialized segments.